Press Releases
Bolt Biotherapeutics Closes $93.5 Million Series C Financing ...
Read More
Read More
Bolt Biotherapeutics Closes $93.5 Million Series C Financing ...
Read More
Read More
Bolt Biotherapeutics Announces Issuance of U.S. Patent for the Boltbody™ ISAC Technology and its Lead Development Candidate, BDC-1001 ...
Read More
Read More
Bolt Biotherapeutics Appoints William P. Quinn as Chief Financial Officer ...
Read More
Read More
Bolt Biotherapeutics Appoints Edith Perez, M.D., as Chief Medical Officer ...
Read More
Read More
Bolt Biotherapeutics Appoints Nathan Ihle, Ph.D., as Vice President of CMC and Quality ...
Read More
Read More
Bolt Biotherapeutics Announces Initiation of BDC-1001 Clinical Trial in Patients with HER2-Expressed Solid Tumors ...
Read More
Read More
Bolt Biotherapeutics Appoints Dr. Nils Lonberg to its Scientific Advisory Board ...
Read More
Read More